Tech Company M&A Transactions
Potentia Pharmaceuticals Acquisition
Potentia Pharmaceuticals was acquired by Apellis Pharmaceuticals. The transaction was announced on 11/21/2014. No transaction price was announced.
Transaction Overview
Company Name
Acquired By
Announced On
11/21/2014
Transaction Type
M&A
Amount
Unknown
M&A Terms
Financial terms of the transaction were not disclosed by the companies.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
201 E. Jefferson Street 312
Louisville, KY 40202
USA
Louisville, KY 40202
USA
Phone
Website
Email Address
Overview
Potentia Pharmaceuticals, Inc. is an early stage biotechnology company focused on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases, with an initial emphasis on diseases of the eye such as age-related macular degeneration.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 11/20/2014: ImThera Medical venture capital transaction
Next: 11/21/2014: OsteoGeneX venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs